$76.76
-4.61 (-5.67%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+18.37%
1Y
+131.00%
YTD
+24.35%
Open$81.23
Previous Close$81.37
Day High$81.50
Day Low$75.87
52W High$88.31
52W Low$32.89
Volume—
Avg Volume1.94M
Market Cap9.50B
P/E Ratio—
EPS$-6.84
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$63.59
Above
SMA 200
$49.97
Above
RSI (14)
55.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
+4.0% upside
Current
$76.76
$76.76
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.69M | 92.89M | 617.31M |
| Net Income | -808,645,149 | -745,447,745 | 113.32M |
| Profit Margin | -891.6% | -847.0% | 18.4% |
| EBITDA | -745,210,112 | -725,135,313 | 314.99M |
| Free Cash Flow | — | — | 143.60M |
| Rev Growth | -2.4% | -2.4% | +3.9% |
| Debt/Equity | 0.59 | 0.59 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |